35. Which of the following is not a factor bypass agent. Factor bypass agents are standard of care for bleeding hemophilia pateints with inhibitor ?
[1] FEIBA
[2] rFVII
[3] Emicizumab
[4] Idracizumab
Answer = [4] Idracizumab
Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran.